© 2020 MJH Life Sciences and HCPLive. All rights reserved.
March 22, 2020
FDA grants emergency use authorization to a rapid point-of-care test to detect COVID-19 infection.
December 11, 2019
Results of a recent study from ASH 2019 is suggesting a combination of navitoclax and ruxolitinib could improve outcomes for patients with myelofibrosis.
December 10, 2019
Results of the phase 2 MANIFEST study presented at ASH 2019 suggest CPI-0610 could be an effective treatment for patients with refractory or intolerant advanced myelofibrosis.
October 14, 2019
The rAAV2/2-ND4 gene therapy GS010 elicited continuous bilateral improvements in BCVA from week 48 to week 96 for patients with Leber hereditary optic neuropathy.